Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Neurocognitive Function in Bipolar Disorder
NCT00314314Phase 3Completed
- Sponsor
- University Health Network
- Start
- May 2006
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Generex Oral-lyn in bipolar disorder (BD), sponsored by University Health Network. Started May 2006; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00314314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314314.